Squarer Ron
SEC-identified person · CIK 1454001 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Nuvalent, Inc. NUVL | Director | filed 2025 - 2026 |
| ADC Therapeutics SA ADCT | Director | filed 2024 - 2026 |
| Travere Therapeutics, Inc. TVTX | Director | filed 2017 - 2026 |
| Deciphera Pharmaceuticals, Inc. NA | Director | filed 2019 - 2024 |
| Array Biopharma INC ARRY | Director · Chief Executive Officer | filed 2012 - 2019 |
| Hospira INC HSP | SVP, Global Marketing | filed 2009 - 2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.